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Abstract Identification of a protein-protein interaction site is 
an important step that has significant potential to clarify 
structure-function relationships of proteins and drug design. 
We propose here a unique predictive method to identify protein- 
protein interaction sites based on the observation that proline is 
the most common residue found in the flanking segments of 
interaction sites [Kini, R.M. and Evans, H.J. (1995) Biochem. 
Biophys. Res. Commun. 212, 1115-11241. Accordingly, the 
interaction sites of proteins might be predicted directly from the 
amino acid sequence based on the presence of proline brackets. 
Using this strategy, we have predicted a polymerization site in 
the epitope of the Au-chain of fibrinogen recognized by a 
monoclonal antibody, 9E9 which inhibits fibrin polymerization 
[Cierniewski, C.S. and Budzynski, A.Z. (1992) Biochemistry 31, 
42&S-4253]. The synthetic peptide comprising this predicted site 
inhibited the coagulation of human blood and allosterically 
interfered in fibrin polymerization. This is the first known 
allosteric polymerization site of fibrinogen. Thus the results 
validate the predicted site and the method for prediction. This 
unique predictive method should help in identifying the interac- 
tion sites of many proteins. 
Key words: Molecular recognition; Bioactive peptide; 
Proline; Fibrinogen; Structure-function relationship; Protein 
engineering 
1. Introduction 
Identifying protein-protein interaction sites, and thereby 
understanding structure-function relationships of proteins, is 
one of the most difficult and time-consuming challenges in 
protein chemistry. A prior knowledge of the location of the 
interaction site would be very useful in these studies. Without 
such knowledge, the studies are often tedious and cumber- 
some. Several methods using structural homology of the pro- 
tein with other proteins, molecular model building and molec- 
ular docking using computer graphics, and theoretical 
deductive methods are being used to obtain an initial indica- 
tion of interaction sites. Earlier, we showed that proline 
brackets often enclose protein-protein interaction sites [ 11. 
These proline residues act as distinct barriers between the 
interaction sites and their neighboring segments, and may 
‘bracket’ (or protect) the integrity and conformation of the 
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site [l]. Proline brackets also help in the presentation of the 
interaction site to its complementary protein and thus facil- 
itate protein-protein interactions [1,2]. In this report, we de- 
scribe a corollary to our hypothesis, that protein-protein in- 
teraction sites can often be identified directly from the amino 
acid sequence of the protein, when proline residues bracket 
the sites. Accordingly, a short 3-7 residue segment enclosed 
between proline residues would be identified as a putative 
protein-protein interaction site. Here, we describe the identi- 
fication of a fibrin polymerization site using this corollary. 
Fibrin monomers, formed by proteolytic cleavage of fibri- 
nogen by thrombin, self-assemble into multistranded fibers by 
a polymerization process forming a ‘soluble’ clot. These poly- 
mers are then covalently linked by the transglutaminase activ- 
ity of factor XIIIa to form an ‘insoluble’ clot [3]. According to 
the prevailing model, the release of fibrinopeptides A and B 
from the amino-terminal end by thrombin cleavage exposes 
some polymerization sites that are complementary to preexist- 
ing sites in the carboxy-terminal domain [4]. Some polymer- 
ization sites have been tentatively identified. Recently, Cier- 
niewski and Budzynski [5] developed three monoclonal 
antibodies that recognized the Aa-chain of fibrinogen and 
inhibited fibrin polymerization. They identified the epitopes 
in fibrinogen recognized by these antibodies and concluded 
that these sites probably play an important role in polymer- 
ization. Since the interaction of antibodies could interfere at 
remote sites, the results only show the possibility of polymer- 
ization sites in these epitopes. The author did not identify 
specific sites in these epitopes. Based on the presence of pro- 
line brackets in one of these epitopes, we predicted that the 
intervening segment is an interaction site which plays a sig- 
nificant role in clot formation. The synthetic peptide interferes 
in blood coagulation and fibrin polymerization supporting the 
predicted site. 
2. Materials and methods 
2. I. Materials 
t-Butyloxycarbonyl (t-BOC) amino acids and trifluoroacetic acid 
were obtained from Advanced Chemtech, Inc., and other reagents 
were obtained from Fisher Scientific. Human fibrinogen (plasmino- 
gen-free, approx. 95% clottable protein) was obtained from Sigma. 
2.2. Peptide synthesis 
We synthesized the peptide HPGIAEFPSRA (peptide PSP-9E9, 
polymerization site peptide based on the epitope recognized by 9E9 
monoclonal antibody) by solid-phase peptide synthesis, using t-BOC 
chemistry on Merrifield resin [6], employing a Milligen/Biosearch 
Model 9600 peptide synthesizer. The peptide was purified by a re- 
verse-phase HPLC system to more than 95% purity, and the yield 
was about 90%. The amino acid composition after 24 h hydrolysis 
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in 6 N HCI at 110°C showed the expected ratios of amino acids. The 
structure was also confirmed by determining the mass by fast atom 
bombardment mass spectra on a Finnegan TSQ 70 mass spectro- 
meter. The mass by mass spectrometry was 1182, whereas the calcu- 
lated molecular weight for the peptide is 1181.3. 
2.3. Coagulation assays 
Various in vitro coagulation assays were used to determine the 
effect of PSP-9E9 on the coagulation of human plasma. Blood from 
healthy volunteers was drawn and anticoagulated with 0.11 M triso- 
dium citrate (1:9; v/v). The coagulation times of human plasma were 
measured at 37°C using a BBL fibrometer. The effect of the peptide 
was determined by measurement of prothrombin time, Stypven time, 
thrombin time and activated partial thromboplastin time assays [7-91. 
The first three clotting assays were performed essentially as described 
earlier [lo]. 
2.4. Fibrin polymerization 
Fibrin monomer was prepared from human fibrinogen according to 
the method of Belitser et al. [ll]. Fibrin polymerization was assayed 
by a stopped-flow method. Each reaction mixture contained equal 
volumes of 170 kg/ml of fibrin monomer in 0.02 M acetic acid and 
0.05 M Tris-HCl buffer, pH 7.3, containing 0.1 M NaCI. The initial 
rate of polymerization was measured as the increase in absorbance at 
350 nm. The effect of PSP-9E9 on the rate of polymerization was 
determined by including various amounts of peptide in 0.05 M sodium 
phosphate buffer, pH 7.3. 
2.5. Fluorescence measurements 
All fluorescence measurements were made at room temperature in a 
Shimadzu RF-5000 recording spectrofluorophotometer at 280 nm ex- 
citation. The effect of various concentrations of PSP-9E9 on the in- 
trinsic fluorescence of fibrin monomers was measured in 0.02 M acetic 
acid. 
2.6. Fibrin fiber ma&length ratios 
Mass/length ratios of fibrin fibers were determined according to the 
method of Carr and Gabriel [12]. Fibrin gels were formed at 0.1 M 
ionic strength in 0.05 M Tris, pH 7.4, containing 5 mM CaClz. The 
final concentrations of human fibrinogen and bovine thrombin in the 
reaction mixture were 1 mg/ml and 1.25 units/ml, respectively. After 
20 h, the gels were scanned from 400 to 800 nm and the mass/length 
ratios were calculated. 
3. Results and discussion 
3.1. Prediction of a Jibrin polymerization site 
In our attempts to understand structure-function relation- 
ships of proteins, we have used both theoretical and experi- 
mental approaches [1,2,13-171. Our recent studies of protein- 
protein interaction sites indicated that proline residues are 
found in the flanking segments of interaction sites at 2.5 times 
higher probability than expected by random distribution [l]. 
We exploited this finding by developing a predictive method 
to identify unknown protein-protein interaction sites based on 
the presence of proline residues, as shown in Fig. 1. When a 
short 3-7 residue segment is bracketed by proline residues, the 
intervening segment would be identified as a potential protein- 
protein interaction site, as a corollary to our survey (Fig. 
lA,B). Cierniewski and Budzynski [5] identified a 34-mer seg- 
ment in the Act-chain of fibrinogen as an epitope recognized 
by a monoclonal antibody (9E9) that inhibits fibrin polymer- 
ization (Fig. 1C). This epitope contains two proline residues. 
Based on our predictive method (Fig. la) we identified the 
segment between these proline residues, GIAEF, as a poten- 
tial fibrin polymerization site. To provide experimental evi- 
dence for the prediction, we synthesized peptide 
HPGIAEFPSRA (named PSP-9E9, see section 2) with the 
predicted site, and studied its effect on blood coagulation 
and fibrin polymerization. 
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Fig. 1. Predictability of protein-protein interaction sites based on 
the presence of proline residues. (A) Proline residues are the most 
commonly found amino acid residues in the flanking segments of 
continuous protein-protein interaction sites [l] (shown as hatched 
area). (B) A corollary to the above finding is that if proline residues 
are separated by a short segment of the sequence, then the interven- 
ing segments are potential interaction sites (shown as cross hatched 
and solid areas). Two independent interaction sites (a,b) are shown 
as an example of a protein containing two sites. (C) Step-by-step 
description of prediction of fibrin polymerization site. In step 1, 
proline residues found in the sequence of the epitope recognized by 
monoclonal antibody 9E9 are highlighted. In step 2, the short inter- 
vening segment between two prolines (underlined) is identified as 
potential polymerization site. Step 3, gives the sequence of the syn- 
thetic peptide, PSP-9E9. 
3.2. Experimental evidence for the predicted site 
We studied the effect of PSP-9E9 on the coagulation of 
human plasma. The clotting time increased in all four assay 
systems with increasing peptide concentration (Fig. 2). The 
dose required for doubling the coagulation time ranged be- 
tween 2.1 and 4.1 mM. Thus although it inhibited coagula- 
tion, the peptide is not a potent inhibitor. Since it inhibited 
coagulation initiated by thrombin, it interferes at either the 
cleavage of fibrinogen to fibrin monomer, or in fibrin poly- 
merization. 
We examined the effect of PSP-9E9 on fibrin polymeriza- 
tion. The initial rate of fibrin polymerization was not affected 
at low concentrations of the peptide, but at higher concentra- 
tions of the peptide, the rate was significantly enhanced (Fig. 
3). The rate of polymerization reached about 20-fold greater 
than the control rates at 1.5 mM peptide. Thus the peptide 
appears to have an allosteric effect on fibrin polymerization. 
This is the first known allosteric site in fibrin polymerization. 
This suggests that interaction of the peptide with fibrin mono- 
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Fig. 2. Effect of PSP-9E9 on coagulation of human plasma. Various amounts of the peptide were incubated with plasma for two min before in- 
itiating the clotting. (0) Activated partial thromboplastin time; (0) prothrombin time; (A) Stypven time; and (A) thrombin time. Each data 
point is an average of at least three independent experiments. Relative clotting times were determined by comparing the clotting times in the 
presence of the peptide to control clotting times. 
mer probably induces subtle conformational changes that en- 
hance the rate of polymerization. Therefore, we examined the 
effect of the peptide on the intrinsic fluorescence of fibrin 
monomers. As shown in Fig. 4, the intrinsic fluorescence 
was somewhat quenched at higher concentrations of the pep- 
tide. This is consistent with a conformational change in fibrin 
monomers upon binding of the peptide. However, PSP-9E9 
did not affect the intrinsic fluorescence of fibrinogen even at 
high concentrations of the peptide (data not shown). The 
dose-response of fluorescence (Fig. 4, inset) paralleled that 
of the initial rates of polymerization (Fig. 3). Thus, from these 
studies, we conclude that PSP-9E9 interacts with fibrin mono- 
mers and allosterically modifies fibrin polymerization. Control 
peptides with unrelated sequences, for example, IARGDMNA 
and ADEFGHIKLMNP, did not show any effect on either 
100 
fibrin polymerization or the intrinsic fluorescence (data not 
shown). 
Finally, we examined the effect of PSP-9E9 on n values 
(mass/length ratio) of the fibrin polymers formed (Fig. 5). 
At lower concentrations of peptide, p decreased (Fig. 5, inset) 
indicating a probable decrease in the thickness of the fibers. In 
contrast, at higher concentrations, there was an increase in the 
n values, and thus probably the thickness of the fibrin fibers. 
Whether the decrease in p values cause decreases in the initial 
rate of fibrin polymerization is unclear. It is also not clear at 
this time why high concentrations of the peptide are required 
to exhibit these effects. It is important to note that protein- 
protein interaction in fibrin polymerization is based on multi- 
point contact. This new site may be one of the low affinity 
sites in these interactions. Further studies are required to clar- 
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Fig. 3. Effect of PSP-9E9 on initial rate of fibrin polymerization. Initial rates were calculated between 0.252 and 4 s. Each data point is an 
average of eight determinations. The inset shows a decrease in the initial rate at lower concentrations of the peptide. 
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Fig. 4. Effect of PSP-9E9 on the intrinsic fluorescence emission of fi- 
brin monomers. Fluorescence emission spectra of fibrin monomers 
with or without peptide. The emission spectra were measured upon 
excitation at 280 nm. Various amounts of the peptide were incu- 
bated with fibrin monomers for one min before fluorescence mea- 
surements were made at room temperature. Typical of two indepen- 
dent measurements. Solid line, no peptide; broken line, 0.5 mM 
peptide; and dotted line, 2 mM peptide. Inset: Effect of peptide on 
emission intensity of fibrin monomers. Excitation, 280 nm; emission, 
345 nm. Each data point is an average of two experiments. 
ify the mechanistic role of this site in fibrin polymerization. 
However, the results demonstrate that PSP-9E9 interacts with 
fibrin monomers and allosterically modifies fibrin polymeriza- 
tion, and thus the site is involved in protein-protein interac- 
tion. Thus, the current studies provide experimental evidence 
that protein-protein interaction sites can be predicted based 
on the presence of proline brackets, a corollary of our hypoth- 
esis [l]. 
3.3. Prediction of other interaction sites 
We have presented here experimental evidence to support 
the prediction of a fibrin polymerization site. To test the cap- 
ability of this new predictive method, we have examined other 
structurally, functionally and phylogenetically unrelated pro- 
teins, and have collected experimental evidence for their pre- 
dicted sites. Although we have data from systematic and de- 
tailed studies of these examples, we have included only the 
summary of some of our results to avoid laborious, confusing 
and lengthy descriptions as each example is from a distinctly 
different field. For example, a new class of serine proteinase 
inhibitor was recently isolated from mustard seed [ 181. We 
identified the reactive site of this inhibitor; the synthetic pep- 
tide, based on the predicted site between residues 18 and 24, 
acts like a substrate-analog inhibitor of trypsin (Kini and 
R.M. Kini, H. J. EvanslFEBS Letters 385 (1996) 81-86 
Evans, unpublished observations). We have also identified 
the interaction site of a calcium channel-blocking toxin from 
black mamba snake venom [19]. As expected, the synthetic 
peptide based on the predicted site shows negative inotropic 
effects on isolated rat hearts. The peptide also specifically 
blocks L-type calcium channels in isolated cardiac muscle cells 
as determined by patch clamp techniques (R.M. Kini et al., 
unpublished observations). Thus, we have predicted protein- 
protein interaction sites in three independent, unrelated exam- 
ples with a success rate of 100% (three out of three). Conse- 
quently, the reliability of this approach is excellent. Hence, we 
have gathered strong experimental evidence for this novel pre- 
dictive method to identify protein-protein interaction sites. 
Obviously no single method can guarantee to identify all pro- 
tein-protein interaction sites. However, the described method 
can help identify a significant number of continuous interac- 
tion sites. This possibility is supported by the presence of 
proline residues in the flanking segments of a large number 
of protein-protein interaction sites [l] and their ability to en- 
hance protein-protein interaction and potency of bioactive 
peptides [1,2]. Although the success rate will no doubt drop 
significantly, a success rate of even 20-30% is a significant step 
toward in identifying interaction sites from amino acid se- 
quences, considering the present rate of 0%. 
3.4. Novel method for prediction of interaction sites 
In this method, short segments of 3-7 residues flanked by 
proline brackets are predicted as potential interaction sites. 
The method also considers lo-residue segments on either 
side of a single proline residue, with preference shown for 
segments containing a cysteine residue, which could form a 
boundary on the other side of the interaction site [l]. The 
number of such predicted sites will be small, because of the 
frequency of occurrence of proline residues (-5%) [20,21]. 
Any other information available can be used either to rule 
3.50 
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0 
1.50 
0.00 2.50 5.00 
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Fig. 5. Effect of PSP-9E9 on the mass/length ratio (u) of fibrin poly- 
mers. The two different symbols used indicate the results of inde- 
pendent experiments. 
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out or to support the prediction of an interaction site. We 
used the experimental evidence presented by Cierniewski and 
Budzynski [S] of the epitope of monoclonal antibodies to pre- 
dict a fibrin polymerization site. The presence of lysine or 
arginine within the site of a trypsin inhibitor, or the location 
of the interaction site on the external loop of a receptor pro- 
tein, would also aid in the prediction. The systematic use of 
information obtained by homology studies can also direct the 
prediction. If available, a three-dimensional model of the pro- 
tein would indicate the accessibility of the sites for interaction. 
Hydrophilicity [22,23], flexibility [24] and surface accessibility 
[25] may also assist in the prediction. Additional information 
is helpful, but not essential for the prediction of interaction 
sites. To our knowledge, this is the first method which allows 
the prediction of protein-protein interaction sites directly from 
the amino acid sequence. 
The predicted site(s) can be critically tested by two distinct 
approaches depending on the facilities and the expertise avail- 
able: (1) direct synthesis of peptides; or (2) site-directed mu- 
tagenesis. The structure of the peptides should include proline 
residues. When cysteine residues are used in the predictive 
step, replacement of these residues by proline should help in 
obtaining peptides with higher potency and specificity. These 
peptides can be directly tested by an assay of their biological 
effects to determine the success of the prediction. Although 
protein-protein interactions are important determinants of the 
biological activity of a protein, the contributions of other 
factors, such as enzymatic activity and role of other domains, 
should also be considered. Therefore, specific binding studies 
and binding competition between the peptide and the native 
protein should also be considered for testing the validity of 
predicted site(s). In site-directed mutagenesis experiments, the 
replacement of specific proline residues may not give informa- 
tive results. Some proteins may retain their native folding even 
after replacement of proline residues because of other factors. 
Therefore, it would be prudent to mutate residues in the inter- 
action site (the intervening segment) rather than the proline 
residues. Negative results in both these approaches only mean 
that the predicted site is not involved in the protein-protein 
interaction of the test system, and it may be necessary to 
examine the role of the site in other systems. Such studies 
may in fact reveal other unknown functions of the protein. 
After identifying the interaction site, further studies would 
also be required to identify the minimal recognition sequence. 
In recent years, the theory of molecular recognition code 
has been used to identify or develop peptides that bind to a 
specific site. According to this theory, peptides encoded by the 
complementary sequences of nucleic acids interact with each 
other with high affinity and specificity [26,27]. The nucleic acid 
sequence of the protein is a mandatory requirement. The 
method also requires the prior knowledge of the interaction 
site of the protein. Without this information, designing the 
specific binding peptide or identifying the complementary 
site in its protein partner is difficult. The knowledge of topo- 
graphic accessibility of a site may help to alleviate this pro- 
blem to a small extent. Sometimes, the complementary strand 
may have a stop codon. Besides the universality of the theory 
is still controversial [28]. 
3.5. Conclusions and future prospects 
We have developed a novel predictive method to identify 
protein-protein interaction sites based on the presence of pro- 
line brackets in the amino acid sequence. Our approach to 
prediction of interaction sites has several attractive features: 
(a) It is simple and straightforward. It reduces blind search for 
interaction sites; (b) it is based on an entirely new concept, 
the recognition of flanking segments, rather than the interac- 
tion sites themselves. The method is open to further improve- 
ment and fine tuning. Further studies of the flanking segments 
may help us improve the predictability using this strategy; 
(c) the only requisite for prediction is the complete amino 
acid sequence of the protein; (d) very little time is required 
to identify and test the predicted site(s) by this approach. In 
many cases, the method could reduce the time required to 
solve structure-function relationships from several years to a 
few short weeks. Thus, the method should have a considerable 
impact on the economics of research and development of no- 
vel bioactive peptides. Even if the method fails to identify the 
site, only a little time would be wasted; (e) the method ap- 
pears to be robust, and can be readily applied to a large 
number of proteins. Thus the predictive method opens several 
avenues in protein chemistry and protein engineering, parti- 
cularly for solving structure-function relationships of pro- 
teins; and (f) based on its excellent reliability, we believe 
that this approach is superior to all existing methods and 
approaches. Since the database covers only continuous inter- 
action sites [l], the predictive method may or may not predict 
discontinuous sites. Finally, this corollary reinforces our hy- 
pothesis dealing with the importance of proline brackets [1,2]. 
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